首页 | 本学科首页   官方微博 | 高级检索  
     

沙利度胺联合VTD方案治疗多发性骨髓瘤的临床研究
引用本文:古茂群,刘传勇,张雄. 沙利度胺联合VTD方案治疗多发性骨髓瘤的临床研究[J]. 右江民族医学院学报, 2007, 29(3): 348-350
作者姓名:古茂群  刘传勇  张雄
作者单位:广东省茂名市人民医院血液科,广东,茂名,525000
摘    要:目的探讨沙利度胺联合VTD方案治疗多发性骨髓瘤(MM)的临床效果及不良反应。方法观察采用沙利度胺(T)、长春新碱(V)、吡喃阿霉素(T)和地塞米松(D)方案联合治疗25例初治性和13例复发难治性MM的效果和不良反应。结果初治MM 25例中15例完全缓解(CR),5例部分缓解(PR),5例进步(I)。复发难治MM 13例中6例CR,4例PR,3例无效。不良反应有乏力、嗜睡、腹胀、便秘及感染等,但均可耐受。结论T-VTD是治疗初治和复发难治MM效果好而又安全的方案。

关 键 词:多发性骨髓瘤  药物疗法,联合  沙利度胺
文章编号:1001-5817(2007)03-0348-03
收稿时间:2006-12-19
修稿时间:2006-12-19

Curative results of Thalidomide plus VTD regimen in treatment of multiple myeloma
GU Mao-qun,LIU Chuan-yong,ZHANG Xiong. Curative results of Thalidomide plus VTD regimen in treatment of multiple myeloma[J]. Journal of Youjiang Medical College For Nationalities, 2007, 29(3): 348-350
Authors:GU Mao-qun  LIU Chuan-yong  ZHANG Xiong
Abstract:Objective To observe the curative effect and side effect of Thalidomide plus vincristine sulphate(V),tetrahydropyrany(T),dexamethasone(D) (T-VTD) regimen in treatment of multiple myeloma(MM).Methods 25 newly diagnosed and 13 relapsed or refractory cases were treated with T-VTD.Clinical and adverse reactions were analyzed.Results For the newly diagnosed 25 cases,15 obtained complete remission(CR),5 partial remission(PR) and 5 improvement(I).For 13 relapsed or refractory cases,6 gained CR,4 PR and 3 no response.The main side effects were fatigue,lethargy,flatulence,constipation and infection,while the side effects were tolerable.Conclusion T-VTD is a highly effective and safe regimen in the treatment of de novo and relapsed or refractory MM.
Keywords:multiple myeloma   drug therapy, combination   Thalidomide
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号